Tag Archives: Anacor Pharmaceuticals

June, 2016

• 24 June

  Pfizer Completes Acquisition of Anacor Pharmaceuticals

  

  NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced that it has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net in cash (without interest but subject to required withholding of …

  Share

  • Facebook
  • Twitter
  • LinkedIn

May, 2016

• 16 May

  Pfizer to Purchase Anacor in $5.2 Billion Deal

  

  Pfizer Inc. (NYSE:PFE) and Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total transaction value, net of cash, of approximately $5.2 billion, which assumes the conversion of Anacor’s …

  Share

  • Facebook
  • Twitter
  • LinkedIn